drugset / Trial / NCT01180894
IV Iron for the Anemia of Traumatic Critical Illness
Completed
150 enrolled
Denver Health and Hospital Authority
National Trauma Research Institute · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this clinical trial is to determine whether intravenous iron supplementation of anemic, critically ill trauma patients improves anemia and reduces the need for a red blood cell transfusion.
Timeline
- Start
- 2011-06
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Iron sucrose | Unknown | 100 mg | Intravenous |